POSTERS thyroid carcinoma, the second case during a parathyroidectomy for primary hyperparathyroidism, and the last case during a partial left thyroidectomy for thyroid goiter.
Objective: Uvulopalatopharyngoplasty (UPPP) is the commonly performed surgical procedure for the treatment of obstructive sleep apnea syndrome (OSAS). The efficacy of this procedure has not been clearly established. Our aim was to assess long-term effects of UPPP for OSAS and the impact of body weight for outcome of UPPP.
Method: We report the results of routine pre-/postoperative OSArelated assessments in patients undergoing UPPP from January 1, 2003 to June 30, 2011. All participants received overnight polysomnography (PSG) and questionnaires regarding daytime sleepiness, snoring severity, and sleep quality before and after the treatment.
Results: Fifty patients completed the study. Forty-two (80%) were male subjects. The average age was 30.7 years. The success of UPPP was defined as AHI reduction more than 50% and post-op AHI <20. The success rate for UPPP was decreased with time (<0.5 year: 81.8%; 0.5-1 year: 44.4%; 1-2 years: 33.3%; 2-3 years: 33.3%; 3-5 years: 42.9%; >5 years: 40.0%). There were 27 patients with body weight reduction after UPPP. In the group of patients with body weight increase after UPPP, snoring index was increasing (P = .0080), AHI was increasing (P = .0512), and ESS was increasing (P = .0182) with longer follow-up period.
Conclusion: Sleep apnea could be resolved for most patients in 6 months after UPPP but recurred with longer post-op period. Body weight change may be an important factor for recurrence. For OSA patients with body weight increase after UPPP, the recurrence rate was higher than patients with body weight reduction.
Head and Neck Surgery Boron Neutron Capture therapy for Squamous Cell Carcinoma of the Skull Base
Takaki Inui, MD (presenter); Shin-Ichi Haginomori, MD Takahiro Ichihara, MD; Atsuko Takamaki, MD; Ryo Kawata, MD Objective: 1) Describe the first case of inoperative squamous cell carcinoma (SCC) in the skull base recurring after surgery, conventional radiotherapy, and chemotherapy, which was treated using 2-stage boron neutron capture therapy (BNCT). 2) Determine the effectiveness of BNCT for head and neck cancer.
Method:
We present a case of inoperative recurrent SCC in the right temporal bone involving the occipital condyle. The patient underwent BNCT twice in 1 month in 2007 at Research Reactor No. 4 of the Japan Atomic Energy Research Institute to ensure neutron capture in the deep lesion.
Results: An epithermal neutron beam was used as the neutron source. The total estimated radiation dose of the BNCT to the tumor beneath the skin, at the deepest point of the tumor, and in the skin around the right auricle was 41.8, 36.9, and 15.8 Gy-Eq, respectively. After the BNCT, the tumor became necrotic and shrank immediately and disappeared 6 months after the first BNCT. Radiological studies performed 5 years after the first BNCT showed no evidence of residual or recurrent tumors.
Conclusion: Total resection of SCC deeply invading the skull base is difficult. Surgical complications can leave patients in critical condition. Two-stage BNCT might be an effective treatment for patients with SCC deep in the skull base. Method: The European Head and Neck Society's "About Face" survey was augmented with questions on demographics and human papilloma virus (HPV). Surveys were administered at 2 community events, and participants could choose to take part in a H&N cancer screening. Knowledge scores were created for correct responses to H&N cancer questions.
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Results: A total of 223 people completed the survey, and 126 participated in the screening: 92% were American Indian, and 32% had pre-existing knowledge of H&N cancer. Mean knowledge scores were 17 (61%) out of 28. Factors that predicted significantly higher H&N cancer knowledge were having or knowing someone with cancer (P = .002), race (P = .02), and education (P = .002). Fifty-nine percent of participants had previous awareness of HPV, but only 36% believed that it was associated with H&N cancer. Ten (8%) people had positive findings on examination. The only significant predictor of a positive finding was smoking history, with all 10 findings being current or past smokers (P = .02).
